glp 1 orforglipron Medscape | Orforglipron, Eli Lilly's investigational oral glucagon-like peptide receptor agonist (GLP-1 RA), achieved positive phase 3 results for Foundayo (Orforglipron): What to Know

Diabetes affecting over 830 million people, which accounts for 14% of adults 18 years or older worldwide (Miller et al., 2025)

[DOI] [Google Scholar] 38.Weiss F., Brancati G.E., Elefante C., Petrucci A., Gemmellaro T., Lattanzi L., Perugi G

Act 2: Glucagon's Hilarious Improv Next up, we have the unpredictable glucagon suppression skit

For the broader picture on training while on Ozempic, Wegovy, or Mounjaro at any age, see our GLP-1 strength training for adults over 40 resource hub

GLP-1 Agonists with SGLT-2 Inhibitors SGLT-2 inhibitors, used in diabetes treatment, may synergize with GLP-1 agonists to enhance weight loss and reduce cardiovascular risk

Willow accepts HSA credit cards , so you can use that to get started